For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment

Description:

For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular Surgery – PowerPoint PPT presentation

Number of Views:81
Avg rating:3.0/5.0
Slides: 34
Provided by: pje8
Category:

less

Transcript and Presenter's Notes

Title: For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment


1
For the motion Endovascular Therapy is a better
option for limb salvage in diabetic ulcer
treatment
  • Dr. Prasad Jetty
  • Division of Vascular and Endovascular Surgery
  • The Ottawa Hospital
  • University of Ottawa

2
Endo vs open surgery for diabetic ulcers
3
(No Transcript)
4
(No Transcript)
5
1. Patency
  • Patency of angioplasty is worse than bypass in
    diabetic ulcer patients
  • YES

Angioplasty patency is worse!
6
1. Patency
  • BUT ARE BYPASSES THAT GREAT???
  • 30-40 of bypasses develop stenoses with in 1 yr
    (Seminars of Vascular Surgery 2012 25108-114)
  • 20-80 of successful patent bypasses have
    recurrent or persistent ulcers or wounds at 1 yr
    (Seminars of Vascular Surgery 2012 25108-114)
  • Too late or bypass flow is not enough
  • Non-ischemic ulcer
  • Occluded bypass does not necessarily mean
    amputation or recurrent ulcer

7
1. Patency
  • With good surveillance post angioplasty one can
    identify restenoses early and can easily and
    safely repeat the endovascular intervention and
    thus rival the patency rates of bypass procedures

8
1. Patency
  • Are vasculopaths really looking for high 5 and 10
    years patencies?
  • 1 year mortality of patients with CLI is 25
    (American College of Cardiology, Canadian
    Cardiovascular Society 2005, 2009 updated
    guidelines)

9
1. Patency
  • Therefore angioplasty may only need to be patent
    long enough until the patient dies from another
    cause or at least long enough to allow for ulcer
    healing, and can easily be repeated if it recurs

10
2. Periprocedural mortality and morbidity
ELDERLY
DIABETES
CORONARY DISEASE
COPD
SMOKER
RENAL FAILURE
DYSLIPIDEMIA
HYPERTENSION
OBESE
11
2. Periprocedural mortality and morbidity
  • Large prospective NSQIP analysis of gt2500
    patients revealed bypass has 20 periprocedural
    complication rate, and 49 readmission rate at 6
    mos (65 are bypass related)
  • (LaMuraglia et al. Significant periooperative
    morbidity accompanies contemporary bypass
    surgery. Eu J Vasc Endo vasc Surg 2012
    43(5)549-55)
  • Conte et al. Diabetic Revascularization Do we
    have the answer Semin Vasc Surg 201225108-114

12
2. Periprocedural mortality and morbidity
  • 10-20 of bypass develop incisional wound
    complications
  • metaanalysis 12 decline in ambulation and 15
    loss of independent living post bypass surgery
  • (LaMuraglia et al. Significant periooperative
    morbidity accompanies contemporary bypass
    surgery. Eu J Vasc Endo vasc Surg 2012
    43(5)549-55)
  • Conte et al. Diabetic Revascularization Do we
    have the answer Semin Vasc Surg 201225108-114

13
2. Periprocedural mortality and morbidity
  • Complications post angioplasty is 2 (groin
    hematomas, pseudoaneurysms) and the patient is
    discharged the same day)
  • (LaMuraglia et al. Significant periooperative
    morbidity accompanies contemporary bypass
    surgery. Eu J Vasc Endo vasc Surg 2012
    43(5)549-55)
  • Conte et al. Diabetic Revascularization Do we
    have the answer Semin Vasc Surg 201225108-114

14
3. Multiple run-off vessels and distal pedal
circulation
15
4. Burning bridges?
You will be burning bridges!
16
4. Burning bridges?
  • BASIL trial
  • Concluded that survival is worse in pts who had
    endo-first failures followed by rescue bypass vs
    bypass-first pts

17
4. Burning bridges?
  • Flawed logic- Selection Bias
  • Pts who failed angioplasty have selected
    themselves out as higher risk
  • Problems with BASIL
  • Extremely highly selective- only 1/10 patients
    randomized actually got the procedure they were
    suppose to get (does not represent the usual
    vascular population)
  • Interventional radiologists did the endo
    procedures vs vascular surgeons
  • Procedures done 12-14 years ago - OUTDATED!!
  • There are some good things about BASIL....

18
4. Burning bridges?
  • BASIL is very good in thai food

19
5. Do all diabetic ulcers with vascular stenoses
or occlusions need revascularization?
NO
Loss of sensation- prone to injury Demyelination
and atrophy of intrinsic muscles Disruption of
normal bony architecture Resultant abnormal
pressure points Impaired immunity and delay in
healing Micro vascular ischemia Macro vascular
ischemia
20
5. Not all diabetic ulcers with vascular
stenoses or occlusions need revascularization
  • some will heal with conservative therapy
  • It is difficult to know exactly who will benefit
  • Tendancy for vascular specialist to revascularize
    in the setting of concomittant vascular disease
    and therefore some patients maybe receiving
    revascularization when it may not be necessary.

21
5. Not all diabetic ulcers with vascular
stenoses or occlusions need revasculariztion
  • An unnecessary bypass may be worse than an
    unnecessary angioplasty

22
Ask Uncle Google
23
(No Transcript)
24
Thank you
  • Division of Vascular and Endovascular surgery
  • The Ottawa Hospital and University of Ottawa

25
Round 1
26
Rebuttal
27
TASC 2 Classification
  • Type A endovascular procedures are recommended
  • Type B endovascular procedures are recommended
    unless an open revascularization procedure
    (surgery) is required for other lesions in the
    same anatomic area
  • Type C open revascularization procedures are
    recommended. Endovascular procedures are only
    recommended in patients who have a low healing
    potential following surgical revascularization
  • Type D endovascular procedures are not
    recommended as first-line treatment

28
TASC guidelines are lesion-centric and do not
emphasize the importance of weighing comorbid
factors and life expectancy
29
6. If you dont embrace endovascular therapy
someone else will
  • It is crucial that the vascular surgeon embraces
    endo and leads innovation in the field otherwise
    we are going towards extinction

30
Evolution
31
(No Transcript)
32
(No Transcript)
33
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com